The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells. (Q46097844)
Jump to navigation
Jump to search
scientific article published on 21 November 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells. |
scientific article published on 21 November 2017 |
Statements
The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells (English)
Serena Pillozzi
Massimo D'Amico
Gianluca Bartoli
Giulia Petroni
Olivia Crociani
Angela Guerriero
Luigi Messori
Mirko Severi
Roberto Udisti
Heike Wulff
K George Chandy
Andrea Becchetti
Annarosa Arcangeli
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference